関連する実験動画
Updated: Sep 9, 2025

06:47
A Murine Model of Vertical Sleeve Gastrectomy
Published on: December 18, 2017
11.2K
GLP- 1とGIPの変化と青少年における体重回復 ブーストが必要ですか?
Mohamed Shehata1, Ahmed Elhaddad2, Mohamed Mansour2
1Tanta University, Tanta, Egypt. mohamedshehata81@hotmail.com.
Obesity surgery
|August 31, 2025
まとめ
スリーブ胃切除手術は 青年の体重を効果的に減らすが 重量回復は起こりうる. セマグルチド治療は,一部の患者の体重回復を逆転させ,GLP- 1アゴニストの可能性を示した.
科学分野:
- 減量手術と代謝研究
- 青春期内分泌と体重管理
背景:
- スリーブ胃切除術 (LSG) は,青少年における一般的な減量術です.
- 長期的な成功には 体重増加と 変動するホルモンの変化が 障害となります
- LSG後のインクレチンホルモン (GLP-1,GIP) の動態を理解することは極めて重要です.
研究 の 目的:
- 青少年におけるLSG後の長期的な体重経路とインクレチンホルモンのレベルを評価する.
- 体重回復の補助療法としてセマグルチドの有効性を評価する.
主な方法:
- LSGを受けた264人の青少年を5年間追跡した.
- 体重,BMI,総体重減少率 (%TWL),過剰体重減少率 (%EWL),GLP-1,GIPの年間測定
- 体重回復率 (WR) は,最低値から≥10%の体重増加と18ヶ月でEWLの<50%と定義され,セマグルチドを投与した患者は62人であった.
主要な成果:
- 平均体重はLSG後に著しく減少し,%EWLは68%でピークに達し,5年目には63%に減少した.
- インクレチン濃度 (GLP-1,GIP) は最初増加し,その後減少した.
- セマグルチド治療は,WR患者で1年以内に平均%EWLを34%から68%に増加させ,代謝併発症は改善した.
結論:
- LSGは,持続的な体重減少と代謝の利点を若者に提供します.
- LSGに対するインクレチンホルモンの反応は,特に体重が回復した患者では,時間とともに弱まります.
- セマグルチドは,青年の体重回復の補助療法として有望である.
関連する概念動画
Glucagon-like Receptor Agonists
416
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416
Insulin: Dosing Regimen and Adverse Effects
253
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
253
Dipeptidyl Peptidase 4 Inhibitors
252
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
252
Hypoglycemia and Glucagon
334
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
334
Oral Hypoglycemic Agents: Glinides
256
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
256
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K

